INS and obesity due to melanocortin 4 receptor deficiency: The greater decline in HOMA-B among patients with obesity is consistent with previous studies, suggesting that elevated HOMA-B at baseline may reflect compensatory hyperinsulinemia that diminishes as insulin sensitivity improves with weight loss through lifestyle intervention [43].